NEO
NeoGenomics Inc
18.50$
+3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -245.7% | – | -33.4% | +6.0% | -358.4% | – | -56.3% | -84.9% | -705.9% | – | – | |
| – | +1.3% | -0.5% | -0.9% | -0.7% | +1.1% | -2.5% | -2.6% | -4.8% | -0.3% | +0.1% | -1.2% | – | |
| – | -2.6% | +11.2% | +13.7% | -4.2% | -1.7% | +29.1% | +13.6% | -15.6% | -22.0% | +19.8% | -14.7% | – | |
| – | – | -872.2% | – | -221.9% | – | – | – | -101.6% | – | – | – | – | |
| – | +65.1% | -20.9% | +134.2% | -17.4% | +7.4% | -61.2% | +40.5% | +31.5% | -5.3% | -36.5% | +64.4% | – | |
| – | -17.4% | -15.5% | -49.7% | -148.1% | +55.5% | – | -361.6% | -97.0% | +2,176.2% | -20.7% | +66.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +6,612.1% | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | -31.0% | -35.7% | +140.9% | -40.1% | -41.6% | +38.1% | -21,431.2% | – | -43.7% | -178.4% | +3,522.5% | – | |
| – | +111.2% | -129.2% | – | -70.2% | -27.3% | -514.7% | – | – | -147.9% | – | – | – | |
| – | – | -393.7% | – | -290.8% | – | – | – | -95.9% | -1,245.3% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.